It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DAWN’s FA Score shows that 1 FA rating(s) are green whileULTA’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DAWN’s TA Score shows that 7 TA indicator(s) are bullish while ULTA’s TA Score has 3 bullish TA indicator(s).
DAWN (@Biotechnology) experienced а +4.31% price change this week, while ULTA (@Specialty Stores) price change was -6.94% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.
The average weekly price growth across all stocks in the @Specialty Stores industry was +0.31%. For the same industry, the average monthly price growth was +3.02%, and the average quarterly price growth was +8.98%.
DAWN is expected to report earnings on Nov 10, 2025.
ULTA is expected to report earnings on Dec 04, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Specialty Stores (+0.31% weekly)The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.
DAWN | ULTA | DAWN / ULTA | |
Capitalization | 769M | 22.1B | 3% |
EBITDA | -108.37M | 1.85B | -6% |
Gain YTD | -40.726 | 13.289 | -306% |
P/E Ratio | N/A | 18.91 | - |
Revenue | 188M | 11.4B | 2% |
Total Cash | 453M | 455M | 100% |
Total Debt | 3M | 1.98B | 0% |
ULTA | ||
---|---|---|
OUTLOOK RATING 1..100 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 40 | |
SMR RATING 1..100 | 19 | |
PRICE GROWTH RATING 1..100 | 48 | |
P/E GROWTH RATING 1..100 | 23 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DAWN | ULTA | |
---|---|---|
RSI ODDS (%) | 3 days ago88% | 3 days ago60% |
Stochastic ODDS (%) | 3 days ago86% | 3 days ago68% |
Momentum ODDS (%) | 3 days ago79% | 3 days ago68% |
MACD ODDS (%) | 3 days ago78% | 3 days ago61% |
TrendWeek ODDS (%) | 3 days ago82% | 3 days ago64% |
TrendMonth ODDS (%) | 3 days ago80% | 3 days ago62% |
Advances ODDS (%) | 5 days ago80% | 5 days ago69% |
Declines ODDS (%) | about 1 month ago81% | 3 days ago59% |
BollingerBands ODDS (%) | 3 days ago74% | 3 days ago82% |
Aroon ODDS (%) | 3 days ago80% | 3 days ago64% |
A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with RVMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then RVMD could also see price increases.
Ticker / NAME | Correlation To DAWN | 1D Price Change % | ||
---|---|---|---|---|
DAWN | 100% | -1.05% | ||
RVMD - DAWN | 50% Loosely correlated | -0.93% | ||
DNLI - DAWN | 50% Loosely correlated | -2.43% | ||
NRIX - DAWN | 49% Loosely correlated | -0.74% | ||
SYRE - DAWN | 49% Loosely correlated | -1.38% | ||
IDYA - DAWN | 48% Loosely correlated | -1.52% | ||
More |
A.I.dvisor indicates that over the last year, ULTA has been loosely correlated with ASO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ULTA jumps, then ASO could also see price increases.
Ticker / NAME | Correlation To ULTA | 1D Price Change % | ||
---|---|---|---|---|
ULTA | 100% | -7.14% | ||
ASO - ULTA | 52% Loosely correlated | -0.20% | ||
HNST - ULTA | 49% Loosely correlated | N/A | ||
AN - ULTA | 46% Loosely correlated | -1.47% | ||
DKS - ULTA | 46% Loosely correlated | -1.06% | ||
CPRT - ULTA | 45% Loosely correlated | +0.12% | ||
More |